A fundamental problem in neurobiology is the excitability of presynaptic
nerve terminals, which is critical for synaptic release of
neurotransmitter. The factors regulating excitability of terminals are
poorly understood. This is due to the extremely small size of vertebrate
nerve terminals, which make intracellular recordings impossible to
obtain. It appears that many classical and peptide neurotransmitter, as
well as nitric oxide and carbon monoxide, can influence the electrical
properties of presynaptic terminals. However, the existing evidence for
such influence is largely indirect, relying on changes in postsynaptic
responses to released transmitter.
In this proposal, a unique model system will be used to study the
electrical properties of vertebrate nerve terminals. The parasympathetic
chick ciliary contains "giant" presynaptic nerve terminal that form cup-
like or calyciform endings on ciliary neurons. We have made
intracellular recordings from these nerve terminals, and find evidence
for a number of ion channels and neurotransmitter receptors on the
terminals. The following fundamental questions will be addressed, Which
ion channels are present on vertebrate nerve terminals, and what role do
they play in regulating the membrane potential of the terminal region?
How do presynaptic neurotransmitter receptors alter the excitability of
nerve terminal? Can neurotransmitter receptors located on presynaptic
nerve terminals be functionally coupled to different ion channels than
are identical receptors situated on the same neuron's soma and dendrites?
Intracellular (sharp) and whole-cell patch clamp recording will be made
from calyciform terminals in intact ciliary ganglia in vitro. Using a
brain slice preparation, similar recordings will be made from neurons in
the chick lateral Edinger-Westphal nucleus, since the large terminal in
the ciliary ganglion originate from cell bodies in this terminal
receptors and similar somatic/dendritic receptors on the same class of
neurons. Both opioids and tachykinins will be used for these studies,
as receptors for both classes of neuropeptides are present on Edinger-
Westphal somas and on calyciform terminals. OF particular interest ar mu
and delta opioid receptors, since our initial results indicate that these
receptors are coupled to different ion channels in the terminal region
than in the somatic region. The mechanisms producing these disparate
responses will be examined using a variety of agents that have inhibitory
or stimulatory effects on G-protein-mediated intracellular pathways.
This proposal seeks to obtain new information regarding factors that can
alter the excitability of presynaptic nerve terminal. The model system
to be used provides a unique opportunity to address several fundamental
questions in neurobiology that are directly relevant to the function of
presynaptic nerve terminals located throughout the nervous system.
Alterations in normal presynaptic terminal excitability may be present
in a number of neurological disease, including epilepsy and Alzheimer's
disease.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
050220722
UEI
JNBLLTBTLLD8
Project Start Date
01-July-1994
Project End Date
30-June-1999
Budget Start Date
01-July-1994
Budget End Date
30-June-1995
Project Funding Information for 1994
Total Funding
$155,308
Direct Costs
$108,380
Indirect Costs
$46,928
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Neurological Disorders and Stroke
$155,308
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01NS033135-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01NS033135-01
Patents
No Patents information available for 1R01NS033135-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01NS033135-01
Clinical Studies
No Clinical Studies information available for 1R01NS033135-01
News and More
Related News Releases
No news release information available for 1R01NS033135-01
History
No Historical information available for 1R01NS033135-01
Similar Projects
No Similar Projects information available for 1R01NS033135-01